Centerra Gold Inc. (0UP5)
London Exchange · UK · prices in CAD · close of 19 Oct 2026
Key indicators
| Last close | CAD 30.87 |
|---|---|
| 52-week range | 9.50 – 33.79 |
| Return, 1 month / 3 months | −0.6% / +45.8% |
| Return, 1 year / 3 years | +216.1% / – |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 50 |
| Volatility (1 year) | 56.1% |
| Worst drawdown (1 year) | -26.0% |
| Average daily value traded | 0.13M CAD |
| Dividend yield | 0.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Centerra Gold Inc. is a gold mining company based in Toronto, Canada. It explores for, develops and operates gold mines, producing gold doré and copper concentrate from mines in Canada and Turkey, and it has historically held mining interests in Kyrgyzstan. Its customers are mainly refiners and metal traders who take gold and copper concentrate for further processing. The company also carries out exploration and development work around its operating mines and other mineral properties.
The shares are listed on the London Exchange in UK under the code 0UP5, and the price on this page is in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Centerra Gold Inc. (0UP5) trades on the London Exchange in UK. It last closed at CAD 30.87 on 19 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 923 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 216.1% and over the last three months it rose 45.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 85 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 20.9% | ||
| From 52-week high | -7.5% | ||
| Momentum | 88 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 45.8% | ||
| 6-month return | 18.1% | ||
| 12-month return, skipping the last month | – | ||
| Stability (higher is calmer) | 40 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 56.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.0% | ||
| Liquidity | 33 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.13M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 65 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 0.9% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −4.7% |
|---|---|
| 1 month | −0.6% |
| 3 months | +45.8% |
| 6 months | +18.1% |
| 1 year | +216.1% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 31.13 / 25.53 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.02 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 19 Aug 2026 | CAD 0.0700 |
| 21 May 2026 | CAD 0.0700 |
| 12 Mar 2026 | CAD 0.0700 |
| 13 Nov 2025 | CAD 0.0700 |
| 21 Aug 2025 | CAD 0.0700 |
| 22 May 2025 | CAD 0.0700 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.